Lv61
2010 积分 2024-02-02 加入
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
1个月前
已完结
Comparative Real-World Safety Profiles of Fibroblast Growth Factor Receptor Inhibitors: A Pharmacovigilance Study
2个月前
已完结
FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potential
2个月前
已完结
149MO Irpagratinib (ABSK-011) plus atezolizumab in first-line (1L) and immune checkpoint inhibitors (ICIs) treated advanced hepatocellular carcinoma (HCC) with FGF19 overexpression (+): Updated results of the phase II ABSK-011-201 study
7个月前
已完结
FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2
7个月前
已完结
Epithelial-Mesenchymal Transition in Metastatic Colorectal Cancer
7个月前
已关闭
Occurrence and prognosis of lung cancer metastasis to major organs: a population-based study
7个月前
已完结
Fibroblast growth factor receptors 1 and 4 combined with lymph node metastasis predicts poor prognosis in oral cancer
7个月前
已完结
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness
7个月前
已关闭
Next-generation isoform-selective fibroblast growth factor receptor inhibitors
7个月前
已完结
皖公网安备34019202002308
